Perspective
Nature Reviews Drug Discovery 2, 751-753 (September 2003) | doi:10.1038/nrd1180
Outlook: A path to improved pharmaceutical productivity
Carl M. Cohen1 About the author
Author affiliations
- Carl M. Cohen provides consultation to the biotechnology industry on organizational and technical matters. Email: carlmcohen@hotmail.com
Top of page
Abstract
The current use of metrics-driven approaches to improve the productivity of pharmaceutical drug discovery will fail. This article presents an approach to the use of performance metrics that has the potential to guide fundamental industry improvement though cooperation.
